Search Results

Oticon, Inc. announced the winners of the Oticon Focus on People Awards, a national awards program celebrating outstanding advocates, hearing care professionals and everyday heroes who make a positive impact on the hearing loss community.

Hearing aid manufacturer Oticon, Inc. is challenging the conventions of hearing aid technology once again.

The 2019 Oticon Focus on People Awards honors 13 outstanding individuals for their contributions to the hearing loss community

Oticon Medical today announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals 18 years or older, with bilateral severe-to-profound sensorineural hearing loss, who obtain limited benefit from appropriately fitted hearing aid(s).

For the fourth consecutive year, the Consumer Technology Association (CTA) has recognized Oticon for their excellence in developing breakthrough hearing technology

Oticon Xceed and Oticon Xceed Play, plus the new Oticon CROS solution for single-sided deafness extend the open sound experience to even more adults and children with hearing loss

12 outstanding individuals recognized for challenging hearing loss perceptions in their communities

Oticon, Inc. sets a new standard in child hearing care with today’s launch of Oticon Opn Play™, a hearing aid designed specifically with the developmental needs of growing children in mind. Building on the success of Oticon Opn™, Opn Play brings the advanced sound processing capabilities of its new Velox S™ platform to children of all ages, from infants to teens.